Literature DB >> 11406265

Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients.

W Land1, H Schneeberger, M Weiss, T Ege, L Stümpfig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11406265     DOI： 10.1016/s0041-1345(01)02114-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients.

Authors:  Eric Thervet; Frank Martinez; Christophe Legendre
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

2.  Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients.

Authors:  Anthony J Hennes; Kimberly E Holdener; William J Burlingham; Didier A Mandelbrot; Sandesh Parajuli; Maha A Mohamed; Neetika Garg; Fahad Aziz; Brad C Astor; Arjang Djamali
Journal:  Transplant Direct       Date:  2020-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.